SELECT PUBLICATIONS
André T et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon
cancer. N Engl J Med 2004;350:2343-51. Abstract
Cassidy J et al. First-line oral capecitabine therapy in metastatic colorectal cancer: A
favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol
2002;13:566-75. Abstract
Haller DG et al. Tolerability of fluoropyrimidines appears to differ by region. Proc ASCO
2006;Abstract 3514.
Hoff PM et al. Comparison of oral capecitabine versus intravenous fluorouracil plus
leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer:
Results of a randomized phase III study. J Clin Oncol 2001;19:2282-92. Abstract
Twelves C et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J
Med 2005;352:2696-704. Abstract
Wolmark N et al. A phase III trial comparing FULV to FULV + oxaliplatin in stage
II or III carcinoma of the colon: Results of the NSABP protocol C-07. Proc ASCO
2005;Abstract 3500.
